Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
Multiple sclerosis: Oligoclonal bands-a useful tool to avoid MS misdiagnosis.
A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
LINGO-1 Interacts with the p75 Neurotrophin Receptor in Intracellular Membrane Compartments.
Characterization of Multiple Sclerosis Plaques Using Susceptibility-Weighted Imaging at 1.5 T: Can Perivenular Localization Improve Specificity of Imaging Criteria?
Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis).
Ocular motor signatures of cognitive dysfunction in multiple sclerosis.
Acute optic neuritis in multiple sclerosis.
Advances of Molecular Imaging for Monitoring the Anatomical and Functional Architecture of the Olfactory System.
Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe.
A modified approach to inducing bone marrow stromal cells to differentiate into cells with mature Schwann cell phenotypes.
Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis.
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.
Macular spectral domain optical coherence tomography findings in Tanzanian endemic optic neuropathy.
Multiple sclerosis and cancer: When two wrongs make a right?
Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis.
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis.
Olfactory Dysfunction in Multiple Sclerosis: Evidence of a Decrease in Different Aspects of Olfactory Function.
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
Role of TRIF Small Interference RNA (siRNA) in Chronic Experimental Allergic Encephalomyelitis (EAE).
Pages
« first
‹ previous
…
584
585
586
587
588
589
590
591
592
…
next ›
last »